Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.
Substance Name: Naltrexone
Role of statins in the treatment of multiple sclerosis.
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.
[Inflammatory brain pseudotumor. A variant of demyelinating disease that simulates high-grade glioma].
Transcriptional enhancers: from properties to genome-wide predictions.
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.
Concurrent saturation transfer contrast in in vivo brain by a uniform magnetization transfer MRI.
No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation.
Psychiatric disorders in neurology.
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
Paroxysmal Hypothermia in Two Patients with Multiple Sclerosis.
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.
Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).
Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
The environment and disease: association or causation?
[Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].
Is it time for a new global classification of multiple sclerosis?
Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis.
The risk of Bipolar Disorders in Multiple Sclerosis.
The initiation and prevention of multiple sclerosis.
Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab.
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis-Report of Two Cases.
Guillain-Barré syndrome in Colombia: where do we stand now?
Pages
« first
‹ previous
…
160
161
162
163
164
165
166
167
168
…
next ›
last »